Oncoinvent ASA (KLDVK) — Capital Reinvestment Ratio
Oncoinvent ASA (KLDVK) has a Capital Reinvestment Ratio of 0.58x as of December 2025, meaning it reinvests 1% of its operating cash flow (Nkr3.64 Million) in capital expenditures (Nkr2.12 Million). Check how tangible is Oncoinvent ASA's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Oncoinvent ASA Capital Reinvestment Ratio (2021–2022)
This chart tracks Oncoinvent ASA's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see how efficiently does Oncoinvent ASA generate cash.
Annual Capital Reinvestment Ratio for Oncoinvent ASA (2021–2022)
Year-by-year Capital Reinvestment Ratio for Oncoinvent ASA from 2021 to 2022. See Oncoinvent ASA free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 32.49x | Nkr373.06K | Nkr12.12 Million | ▼ -86.3% |
| 2021 | 236.36x | Nkr130.66K | Nkr30.88 Million | — |